Page 26 - Initial Public News Today

Macrotech Developers Limited subscribed 35% on Day 2 Posted On: 2021-04-08 08:15:41 (Time Zone: Arizona, USA) Affordable and Mid Income Housing focused Macrotech Developers Limited also known as Lodha Developers; received bids of 1,26,56,070 shares against the offered 36,193,415 equity shares, as per the 5:00 pm data available on the bourses. The portion reserved for retail investors was subscribed 0.25 times. While the Qualified Institutional Buyer category was subscribed 0.66 times, the ...

The company has allocated 1.52 crore shares at Rs 486 per share to these anchor investors. A total of 12 foreign portfolio investors who participated in the anchor were Capital Group; Nomura; Ivanhoe Cambridge, real estate arm of CDPQ; Wellington Asset Management; Abu Dhabi Investment Authority, Abu Dhabi’s sovereign fund; Platinum Asset Management, Marshall Wace, Brookfield Asset Management, Segantii Capital, York, Oxbow and Discovery. These foreign investors were allocated around 1.45 crore...

THE STANDARD By Frankline Sunday | April 7th 2021 at 00:00:00 GMT +0300 Following the 1992 General Election, the World Bank and the International Monetary Fund (IMF) turned up pressure on the Kenyan government to introduce structural economic reforms. This was the post-Cold War era and after the break-up of the Soviet Union, the West stepped up its foreign policy and influence in a bid to maintain strong ally-ship that had saved the world in the Second World War.  The Bretton Woods instituti...

Macrotech Developers raises 740 Cr from 14 Anchor Investors Posted On: 2021-04-06 10:21:22 (Time Zone: Arizona, USA) Affordable and Mid Income Housing focused Macrotech Developers Limited also known as Lodha Developers has raised Rs. 740 crore from 14 anchor investors. The company informed the bourses that it has allocated 1.52 Cr shares at Rs. 486 per share on Tuesday, April 6, 2021 to anchor investors. 12 Foreign Portfolio Investors who participated in the anchor were Capital Group; Nomu...

UK Mortgages Ltd - Interim Report & Accounts PR Newswire For the period from 1 July 2020 to 31 December 2020 Legal Entity Identifier: 549300388LT7VTHCIT59 (Classified Regulated Information, under DTR 6 Annex 1 section 1.2) The Company has today released its Interim Management Report and Unaudited Condensed Consolidated Financial Statements for the period ended 31 December 2020. The Report will shortly be available from the Companys Portfolio Managers website: www.ukmortgageslimited.com and will...

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy. OK By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to cont...

To print this article, all you need is to be registered or login on Mondaq.com. For any company, going public is fraught with securities litigation risks. As highlighted in the recent New York State Appellate Court decision In The Matter of Sundial Growers, Inc. Securities Litigation, companies operating in the relatively new, but rapidly growing, frontier of legal cannabis must be thorough and careful when issuing public disclosures. Companies must also be aware of ven...

Brazil retail sales fall in January for third month in a rowBrazilian retail sales fell in January for a third consecutive month, official figures showed, largely in line with expectations…

The Ministry of Justice has been foot dragging on exempting the company from the obligation to report on classified defense activities.

Hyloris Pharmaceuticals: Hyloris Reports Full Year 2020 Financial Results On track to fuel the pipeline with =4 new product candidates in 2021 Strong cash position of €64 million year-end to execute ambitious growth plan 14 commercial products expected by 2024 Conference call and Liège, Belgium - 9 March 2021 - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populati...